Protect Pharmaceutical’s Agropharm A Fertilizer Shown To Increase Crop Yields By As Much As 30%
So far every demonstration of the Companys products on industrial agricultural locations has had a 100% success rate in increasing crop yields and resulted in new orders placed for our products.
Sevnica, Slovenia, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.“OTC:(PRTT)” is pleased to announce another successful application of its Agropharm A product fertilizer in Istria, Croatia. Agropharm A was tested on a lettuce farm that produces snail feed for industrial snail production. The product was applied to the client’s field in three treatments in the following manner:
Method and time of treatment with Agropharm A:
| - | First treatment (July 8, 2020): Soaking seedlings (containers) in concentration 2:50 (2L css:50L H2O) for 1 minute before transplanting; | |
| - | Second treatment (July 13, 2020): 7 days after transplanting, foliar use (1:50); | |
| - | Third treatment (July 23, 2020): Foliar use (1:50), 15 days after first use combined with a fungicide application (Sygnum) for prevention of disease (Botrytis Cinerea); | |
| - | The first harvest was collected on August 2nd, 2020 |
Compared with the control field, lettuce treated with Agropharm A increased both leaf size by 30% bigger and crop weight by at least 25%.
“So far every demonstration of the Company’s products on industrial agricultural locations has had a 100% success rate in increasing crop yields and resulted in new orders placed for our products. This shows a very promising trend in Protect Pharmaceutical’s plans to become Europe’s leading bio-fertilizer provider” comments Angela Savcenco, Director of European Operations.
Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information contact:
Protect Pharmaceutical Corp.
(801) 432-0405
[email protected]